| Mitchell I Edelson, MD | |
|
3941 Commerce Ave, Willow Grove, PA 19090-1104 | |
| (215) 481-4000 | |
| (215) 576-0740 |
| Full Name | Mitchell I Edelson |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 33 Years |
| Location | 3941 Commerce Ave, Willow Grove, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255305546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | MD064402L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Health Home Care And Hospice | Willow grove, PA | Home health agency |
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Abington Memorial Hospital | Abington, PA | Hospital |
| Abington Health Lansdale Hospital | Lansdale, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
Mice can be used to study the neural circuits underlying complex decision-making, suggests an analysis of more than 500,000 mouse decisions reported in JNeurosci.
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Victorian hospitals have been provided with a 51-page dossier on how to conduct a lockout of nurses in a move slammed by the Australian Nursing Federation. This dossier was sent by the Hospitals Industry Association last week and includes templates for letters to be sent to nurses if they are to have their pay docked.
› Verified 6 days ago
| Entity Name | Einstein Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760434468 PECOS PAC ID: 2769395896 Enrollment ID: O20040219000728 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
Mice can be used to study the neural circuits underlying complex decision-making, suggests an analysis of more than 500,000 mouse decisions reported in JNeurosci.
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Victorian hospitals have been provided with a 51-page dossier on how to conduct a lockout of nurses in a move slammed by the Australian Nursing Federation. This dossier was sent by the Hospitals Industry Association last week and includes templates for letters to be sent to nurses if they are to have their pay docked.
› Verified 6 days ago
| Entity Name | Aria Health Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750949806 PECOS PAC ID: 3577467018 Enrollment ID: O20040224000045 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
Mice can be used to study the neural circuits underlying complex decision-making, suggests an analysis of more than 500,000 mouse decisions reported in JNeurosci.
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Victorian hospitals have been provided with a 51-page dossier on how to conduct a lockout of nurses in a move slammed by the Australian Nursing Federation. This dossier was sent by the Hospitals Industry Association last week and includes templates for letters to be sent to nurses if they are to have their pay docked.
› Verified 6 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750306726 PECOS PAC ID: 3274437736 Enrollment ID: O20060524000014 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
Mice can be used to study the neural circuits underlying complex decision-making, suggests an analysis of more than 500,000 mouse decisions reported in JNeurosci.
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Victorian hospitals have been provided with a 51-page dossier on how to conduct a lockout of nurses in a move slammed by the Australian Nursing Federation. This dossier was sent by the Hospitals Industry Association last week and includes templates for letters to be sent to nurses if they are to have their pay docked.
› Verified 6 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1316189855 PECOS PAC ID: 3274437736 Enrollment ID: O20091218000204 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
Mice can be used to study the neural circuits underlying complex decision-making, suggests an analysis of more than 500,000 mouse decisions reported in JNeurosci.
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Victorian hospitals have been provided with a 51-page dossier on how to conduct a lockout of nurses in a move slammed by the Australian Nursing Federation. This dossier was sent by the Hospitals Industry Association last week and includes templates for letters to be sent to nurses if they are to have their pay docked.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell I Edelson, MD 3941 Commerce Ave, Willow Grove, PA 19090-1104 Ph: (215) 481-4000 | Mitchell I Edelson, MD 3941 Commerce Ave, Willow Grove, PA 19090-1104 Ph: (215) 481-4000 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
Mice can be used to study the neural circuits underlying complex decision-making, suggests an analysis of more than 500,000 mouse decisions reported in JNeurosci.
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Victorian hospitals have been provided with a 51-page dossier on how to conduct a lockout of nurses in a move slammed by the Australian Nursing Federation. This dossier was sent by the Hospitals Industry Association last week and includes templates for letters to be sent to nurses if they are to have their pay docked.
› Verified 6 days ago
Sherry L Blumenthal, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Frank Theodore Sandsorum Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2300 Computer Rd, Ste E25, Willow Grove, PA 19090 Phone: 215-659-8080 Fax: 215-659-0977 | |
Vahideh T Ameri, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 735 Fitzwatertown Rd, Suite 4, Willow Grove, PA 19090 Phone: 215-914-4400 Fax: 215-657-4887 | |
Patricia Ann Sullivan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd Ste C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Joseph James Murphy Iii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2300 Computer Rd Ste E25, Willow Grove, PA 19090 Phone: 215-366-1160 Fax: 215-672-6853 | |
Jessica M. Klemens, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Dr. Elizabeth Burton, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3941 Commerce Ave, Willow Grove, PA 19090 Phone: 215-481-4000 |